Atomo Diagnostics (ASX:AT1) Net Change in Cash : A$-3.61 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Atomo Diagnostics's Net Change in Cash for the six months ended in Dec. 2024 was A$-0.79 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was A$-3.61 Mil.

Atomo Diagnostics Net Change in Cash Historical Data

The historical data trend for Atomo Diagnostics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics Net Change in Cash Chart

Atomo Diagnostics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Net Change in Cash

25.25

-9.16

-4.98

-6.50

-2.78

Atomo Diagnostics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Change in Cash	Get a 7-Day Free Trial						-2.81	-3.69	0.04	-2.82	-0.79

Atomo Diagnostics Net Change in Cash Calculation

Atomo Diagnostics's Net Change in Cash for the fiscal year that ended in Jun. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-4.686	+	-0.016	+	1.867	+	0.053
	=	-2.78

Atomo Diagnostics's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.727 + -0.041 + -0.097 + 0.073

= -0.79

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-3.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atomo Diagnostics Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Atomo Diagnostics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Atomo Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » Net Change in Cash

Comparable Companies

ASX:CBL ASX:HMD ASX:ADRDA ASX:UCM ASX:OSL ASX:UBI ASX:IRX ASX:LDX ASX:CDX ASX:NTI ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE

Traded in Other Exchanges

N/A

Address

3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040

Website

https://www.atomodiagnostics.com

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines